|
1
|
Rodriguez-Abreu D, Bordoni A and Zucca E:
Epidemiology of hematological malignancies. Ann Oncol. 18:(Suppl
1). i3–i8. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alizadeh AA, Eisen MB, Davis RE, Ma C,
Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al:
Distinct types of diffuse large B-cell lymphoma identified by gene
expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shaffer AL III, Young RM and Staudt LM:
Pathogenesis of human B cell lymphomas. Annu Rev Immunol.
30:565–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iqbal J, Sanger WG, Horsman DE, Rosenwald
A, Pickering DL, Dave B, Dave S, Xiao L, Cao K, Zhu Q, et al:
BCL2 translocation defines a unique tumor subset within the
germinal center B-cell-like diffuse large B-cell lymphoma. Am J
Pathol. 165:159–166. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kramer MH, Hermans J, Wijburg E, Philippo
K, Geelen E, van Krieken JH, de Jong D, Maartense E, Schuuring E
and Kluin PM: Clinical relevance of BCL2, BCL6, and MYC
rearrangements in diffuse large B-cell lymphoma. Blood.
92:3152–3162. 1998.PubMed/NCBI
|
|
6
|
Lenz G, Wright GW, Emre NC, Kohlhammer H,
Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, et al:
Molecular subtypes of diffuse large B-cell lymphoma arise by
distinct genetic pathways. Proc Natl Acad Sci USA. 105:13520–13525.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pasqualucci L, Trifonov V, Fabbri G, Ma J,
Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, et
al: Analysis of the coding genome of diffuse large B-cell lymphoma.
Nat Genet. 43:830–837. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morin RD, Johnson NA, Severson TM, Mungall
AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, et
al: Somatic mutations altering EZH2 (Tyr641) in follicular and
diffuse large B-cell lymphomas of germinal-center origin. Nat
Genet. 42:181–185. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kowalczyk MS, Higgs DR and Gingeras TR:
Molecular biology: RNA discrimination. Nature. 482:310–311. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jardin F and Figeac M: MicroRNAs in
lymphoma, from diagnosis to targeted therapy. Curr Opin Oncol.
25:480–486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: LncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
|
12
|
Yang F, Zhang L, Huo XS, Yuan JH, Xu D,
Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, et al: Long non-coding
RNA high expression in hepatocellular carcinoma facilitates tumor
growth through enhancer of zeste homolog 2 in humans. Hepatology.
54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tahira AC, Kubrusly MS, Faria MF, Dazzani
B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado MC
and Reis EM: Long non-coding intronic RNAs are differentially
expressed in primary and metastatic pancreatic cancer. Mol Cancer.
10:1412011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote
cancer metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McCleland ML, Mesh K, Lorenzana E, Chopra
VS, Segal E, Watanabe C, Haley B, Mayba O, Yaylaoglu M, Gnad F, et
al: CCAT1 is an enhancer-templated RNA that predicts BET
sensitivity in colorectal cancer. J Clin Invest. 126:639–652. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li LJ, Chai Y, Guo XJ, Chu SL and Zhang
LS: The effects of the long non-coding RNA MALAT-1 regulated
autophagy-related signaling pathway on chemotherapy resistance in
diffuse large B-cell lymphoma. Biomed Pharmacother. 89:939–948.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Trimarchi T, Bilal E, Ntziachristos P,
Fabbri G, Dalla-Favera R, Tsirigos A and Aifantis I: Genome-wide
mapping and characterization of Notch-regulated long non-coding
RNAs in acute leukemia. Cell. 158:593–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Doose G, Haake A, Bernhart SH, López C,
Duggimpudi S, Wojciech F, Bergmann AK, Borkhardt A, Burkhardt B,
Claviez A, et al: ICGC MMML-Seq Consortium: MINCR is a MYC-induced
lncRNA able to modulate MYC's transcriptional network in Burkitt
lymphoma cells. Proc Natl Acad Sci USA. 112:E5261–E5270. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sehgal L, Mathur R, Braun FK, Wise JF,
Berkova Z, Neelapu S, Kwak LW and Samaniego F: FAS-antisense 1
lncRNA and production of soluble versus membrane Fas in B-cell
lymphoma. Leukemia. 28:2376–2387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou M, Zhao H, Xu W, Bao S, Cheng L and
Sun J: Discovery and validation of immune-associated long
non-coding RNA biomarkers associated with clinically molecular
subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer.
16:162017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ciechanover A: Proteolysis: From the
lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol.
6:79–87. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hochstrasser M: Ubiquitin, proteasomes,
and the regulation of intracellular protein degradation. Curr Opin
Cell Biol. 7:215–223. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ciechanover A: The ubiquitin-proteasome
proteolytic pathway. Cell. 79:13–21. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ciechanover A: The ubiquitin-proteasome
pathway: On protein death and cell life. EMBO J. 17:7151–7160.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang JE, Peterson C, Choi S, Eickhoff JC,
Kim K, Yang DT, Gilbert LA, Rogers ES, Werndli JE, Huie MS, et al:
VcR-CVAD induction chemotherapy followed by maintenance rituximab
in mantle cell lymphoma: A Wisconsin Oncology Network study. Br J
Haematol. 155:190–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
O'Connor OA: Marked clinical activity of
the proteasome inhibitor bortezomib in patients with follicular and
mantle-cell lymphoma. Clin Lymphoma Myeloma. 6:191–199. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stegh AH: Targeting the p53 signaling
pathway in cancer therapy - the promises, challenges and perils.
Expert Opin Ther Targets. 16:67–83. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sherr CJ: G1 phase progression: Cycling on
cue. Cell. 79:551–555. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang X, Lian Z, Padden C, Gerstein MB,
Rozowsky J, Snyder M, Gingeras TR, Kapranov P, Weissman SM and
Newburger PE: A myelopoiesis-associated regulatory intergenic
non-coding RNA transcript within the human HOXA cluster. Blood.
113:2526–2534. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Su X, Malouf GG, Chen Y, Zhang J, Yao H,
Valero V, Weinstein JN, Spano JP, Meric-Bernstam F, Khayat D, et
al: Comprehensive analysis of long non-coding RNAs in human breast
cancer clinical subtypes. Oncotarget. 5:9864–9876. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou Y, Gong B, Jiang ZL, Zhong S, Liu XC,
Dong K, Wu HS, Yang HJ and Zhu SK: Microarray expression profile
analysis of long non-coding RNAs in pancreatic ductal
adenocarcinoma. Int J Oncol. 48:670–680. 2016.PubMed/NCBI
|
|
32
|
Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu
Z, Ye G, Zhang X, Xiao B and Guo J: Gastric juice long non-coding
RNA used as a tumor marker for screening gastric cancer. Cancer.
120:3320–3328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu M, Xing LQ and Liu YJ: A three-long
non-coding RNA signature as a diagnostic biomarker for
differentiating between triple-negative and non-triple-negative
breast cancers. Medicine. 96:e62222017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma KX, Wang HJ, Li XR, Li T, Su G, Yang P
and Wu JW: Long non-coding RNA MALAT1 associates with the malignant
status and poor prognosis in glioma. Tumour Biol. 36:3355–3359.
2015. View Article : Google Scholar : PubMed/NCBI
|
